Medtronic plc (0Y6X.L) LSE

Currency In USD

AD

Medtronic plc

Address

20 On Hatch

Galway, 2

United States of America (the)

Phone

353 1 438 1700

Sector

Healthcare

Industry

Medical - Devices

Employees

95000

First IPO Date

March 06, 2017

Key Executives

NameTitlePayYear Born
Geoffrey Straub MarthaChairman of the Board & Chief Executive Officer3.81M1970
Thierry PietonExecutive Vice President & Chief Financial Officer421,7661970
Michelle QuinnExecutive Vice President, General Counsel & Secretary985,5741969
Brett A. WallExecutive Officer1.86M1966
Matthew WalterSenior Vice President of Human Resources, IT and Global Communications & Corporate Marketing01979
Rogerio BrancoSVP & Chief Operations and Supply Chain Officer0N/A
Mark PloofSenior Vice President of Global Operations and Business Services0N/A
Denise L. BlomquistVice President, Global Controller & Chief Accounting Officer0N/A
Laura MauriSenior Vice President and Chief Scientific & Medical Officer01970
Alex GuSenior VP & President of Greater China Region0N/A
Jason WeidmanSenior VP and President of Coronary & Renal Denervation business0N/A
Ingrid GoldbergVice President & Head of Investor Relations0N/A
AD

Description

Medtronic plc operates on a global scale, designing, producing, and distributing sophisticated device-based medical treatments. These solutions cater to a broad spectrum of users, including healthcare systems, medical practitioners, clinicians, and patients worldwide. Within its Cardiovascular division, Medtronic supplies a comprehensive array of products aimed at heart health. This includes implantable devices such as pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices. The segment also covers cardiac ablation solutions, compact insertable cardiac monitors, TYRX products, and sophisticated remote monitoring and patient-focused software. Furthermore, it delivers various valve technologies, including aortic valves, items for surgical valve replacement and repair, and transcatheter pulmonary valves. The portfolio extends to advanced endovascular stent grafts and their associated accessories, alongside percutaneous coronary intervention (PCI) tools and angioplasty balloons. The Medical Surgical division provides a wide spectrum of offerings for operating rooms and beyond. These encompass surgical instruments like stapling devices, vessel sealing tools, wound closure solutions, and electrosurgery products. It also embraces cutting-edge technologies such as surgical artificial intelligence and robotic-assisted surgery platforms. Specialized products address hernia repair (mechanical devices and mesh implants), gynecology, and lung conditions. Additionally, this segment extends into minimally invasive diagnostics and treatments for gastrointestinal and hepatological conditions, patient monitoring systems, therapies for airway management and ventilation, and solutions for renal disease. Medtronic's Neuroscience division caters to a diverse group of medical professionals, including spinal and neurosurgeons, neurologists, pain management experts, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, interventional radiologists, and ENT specialists. Its product range features advanced energy surgical instruments, sophisticated image-guided and intra-operative imaging systems, and robotic guidance platforms specifically for robot-assisted spinal operations. Moreover, the segment delivers critical therapies for the cerebral and surrounding vasculature. Finally, the Diabetes Operating Unit focuses on solutions for diabetes management, supplying insulin pumps with associated consumables, continuous glucose monitoring (CGM) systems, and intelligent insulin pen systems, along with their necessary supplies. Established in 1949, Medtronic maintains its corporate headquarters in Dublin, Ireland.

AD